VTGN
VistaGen Therapeutics Inc
0.2471$
-1.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +48.0% | -52.0% | -57.4% | +117.9% | +27.9% | -106.4% | – | +5.7% | +17.4% | +53.5% | +217.4% | – | |
| – | +2.1% | +2.3% | +3.1% | +4.0% | +2.5% | +0.0% | +5.0% | – | – | +105.8% | -49.4% | – | |
| – | +48.0% | -52.0% | -57.4% | +117.9% | +27.9% | -106.4% | – | +244.0% | -55.8% | +307.9% | +175.1% | – | |
| – | +17.8% | +63.9% | +2.8% | +33.6% | +10.7% | -9.7% | +14.4% | +36.3% | -11.0% | -7.8% | -16.5% | – | |
| – | +17.2% | +9.6% | +10.8% | -8.1% | -3.5% | +5.5% | +2.3% | +0.6% | +24.9% | -24.9% | -4.9% | – | |
| – | +17.5% | +39.3% | +5.7% | +18.0% | +6.6% | -5.7% | +9.7% | +27.9% | -3.2% | -12.6% | -14.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | -10,166.7% | – | -201,371.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.